Information:
Fel:
Nyckelord
Registers ×
- Lymphoma, Non-Hodgkin (30)
- Leukemia (8)
- AML (7)
- Hematology (4)
- Lymphoma (3)
- Myelodysplastic Syndromes (2)
- Bone Marrow Transplantation (1)
- ALL (1)
- Registration (1)
- Treatment Form (1)
- COVID-19 (1)
- Documentation (1)
- Follow-Up Studies (1)
- HIV (1)
- Pediatrics (1)
Innehållsförteckning
Valda datamodeller
Du måste vara inloggad för att välja flera datamodeller, ladda ner dem eller analysera dem.
45 Sökresultat.
Item-grupper: EBMT FORM GENERAL INFORMATION, PATIENT, DISEASE, SPECIFICATIONS OF THE DISEASE, STATUS OF DISEASE AT HSCT, ADDITIONAL TREATMENT POST-HSCT, BEST DISEASE RESPONSE AT 100 DAYS POST-HSCT, FORMS TO BE FILLED IN
Item-grupper: Patient Information, Eligibility Criteria, Steroid therapy and chemotherapy regimen, Concomitant studies and storage of clinical samples, Laboratory Diagnostic, Identification and Signature
Item-grupper: Signed informed consent available for participation in the registry and consultation, Signed informed consent available for data transfer, data storage, and data handling ..., Storage of remaining bio material with contact for each scientific usage, Storage and use of remaining bio material for the following research projects (pseudonymized) for all NHL, Storage and use of remaining bio material for the following research projects (pseudonymized) FOR LYMPHOBLASTIC LYMPHOMA, Storage and use of remaining bio material for the following research projects (pseudonymized) FOR MATURE B-CELL LYMPHOMA, Storage and use of remaining bio material for the following research projects (pseudonymized) FOR LARGE CELL ANAPLASTIC LYMPHOMA (ALCL)
Item-grupp: Treatment
Item-grupp: Significant treatment modifications and other remarks concerning the treatment
Item-grupp: Subsequent neoplasm
Item-grupp: Treating center
Item-grupper: Chemotherapy, CNS-Radiotherapy
Item-grupp: Chemotherapy
Item-grupp: SCT as part of first-line therapy
Item-grupp: Progression / Relapse
Item-grupper: Reference cytology done?, Reference cytology BEFORE start of therapy: Bone Marrow (BM), Reference cytology BEFORE start of therapy: Cerebral Spinal Fluid (CSF), Reference cytology BEFORE start of therapy: Tumor, Reference cytology BEFORE start of therapy: Effusions, Further remarks